CD8A and acute lymphoblastic leukemia: One study of tisa-cel-treated patients with LBCL and B-ALL suggested that a higher count of TSCM-like cells in the apheresis, characterized by CD8+CD45RA+CD27+ expression, was related to the efficacy of CAR-T cell therapy [51].